(Indianapolis, IN) – The menu for Medicaid-covered medications in Indiana will soon include GLP-1s.
Recently Governor Mike Braun directed the Indiana Family and Social Services Administration (FSSA) to opt into the Center for Medicare and Medicaid Innovation’s BALANCE demonstration. BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) is a federal pilot program targeting obesity.
Soon certain Indiana Medicaid recipients will be eligible for GLP-1s, a popular hormone treatment that regulates blood sugar, slows digestion, and controls appetite. GLP-1s treat conditions like Type 2 diabetes and support weight management…